9:15am ET
Investing
Prediction: This Will Be the Biggest Pharma Stock in 10 Years
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
Companies
/Healthcare
Merck & Co Inc
$148.08
▼ $2.83 (−1.88%) today
Markets closed · 12:49am ET
MRK Coverage
Page 10
1:30pm ET
Companies and Brands
This Massive Product Recall Cost Over $24 Billion
24/7 Insights The most shocking recall on this list is the 1982 Tylenol recall. Recalling the Galaxy Note 7 was a huge blow to Samsung’s brand. Shockingly, only two companies listed here…
8:44am ET
Investing
Deutsche Bank Has 4 Sizzling ‘Fresh Money’ Dividend Stock Picks for Q3
24/7 Insights With the S&P 500 up 15% year-to-date, a correction could be coming in the third quarter. Stocks that pay dividends will be in big demand when interest rates start to…
9:15am ET
Investing
Eli Lilly Stock Price Prediction: Where Will It Be in 1 Year
Wall Street expectations for where Eli Lilly stock is headed this year vary considerably, but some analysts still have faith.
10:10am ET
Investing
Buy These 7 Dividend Stocks and Hold Forever
24/7 Insights Quality dividend stocks outperform non-dividend stocks for shareholders. Dividend stocks can deliver dependable passive income streams. Access 2 legendary, high-yield dividend stocks Wall Street loves. Since 1926, dividends have contributed…
9:30am ET
Investing
Want $22,500 in Passive Income? Invest $20,000 in These Dividend Stocks
24/7 Wall Street Insights With inflation showing few signs of appreciable reversal, prices for other goods and services will inevitably continue to rise. Among the passive income options available to the majority…
1:01pm ET
Investing
3 No-Brainer Nasdaq Stocks to Buy in June
24/7 Insights The Nasdaq is up a stunning 14.5% this year after a massive 43% gain in 2023. Nasdaq dividend stocks are still reasonably priced, including Cisco Systems Inc. (NASDAQ: CSCO |…
9:30am ET
Investing
Discover the Stocks the Political Elite Bought and Sold This Month
It defies all reason that elected officials are allowed to buy and sell stock in an economy that they are actively involved in running and are in charge of making the laws…
8:53am ET
Investing
JP Morgan Has 5 Blue Chip Passive Income Stocks as Top Picks for May
24/7 Insights AI stocks are facing headwinds and sky high valuations are cooling down J.P. Morgan’s top picks are in May are stable, established brands 2 legendary, high-yield dividend stocks Wall Street…
12:30pm ET
Health and Healthcare
These Are the Drugs America Is Running Short On
Private healthcare sure does seem to be working well in America, doesn’t it? With skyrocketing healthcare costs with diminishing returns, a lower life expectancy, unofficial waitlists, and absurdly high mortality rates for…
9:35am ET
Investing
Want $2000 In Passive Income? Invest $1000 Into These Dividend Stocks
On the cover of the Friday, April 12, 2024 edition of The Wall Street Journal, the headline read: “Cost of Owning a Home Soars”. The article cited one family whose home insurance…
7:58am ET
Investing
6 Gold Standard Dividend Stocks Passive Income Investors Need to Buy
Investors love dividend stocks because they provide dependable income and a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions realized over time. In other words,…
10:25am ET
Investing
Leading Wall Street Firm Loves 5 Dividend Blue-Chips As Top 2024 Picks
Every year, the top Wall Street firms release a list of their top stock picks for the coming 12 months, and typically, they are companies that the stock analysts have incredibly high…
9:49am ET
Investing
How Safe Is AbbVie Stock’s 3.7% Dividend?
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
9:10am ET
Investing
7 Rock-Solid Healthcare Dividend Stocks to Buy in January
Fourth-quarter earnings kick off in a big way in 7 to 10 days, and earnings at some of the biggest and best U.S. companies are likely expected to decline for the third…